European Infrastructure of Open Screening Platforms for Chemical Biology — European Research Infrastructure Consortium

Acronym

EU-OS FI

Description of the granted funding

Chemical biology, the development of new small molecules with specific biological activities, is of tremendous value as the starting point for understanding biological processes and for discovering new drugs, agrochemicals and other commercially valuable bioactive agents. EU-OPENSCREEN ERIC (EU-OS, www.eu-openscreen.eu) provides open access to world class chemical biology infrastructures, technologies and expertise, with a compound collection of > 100 000 compounds and open database. As founding member, Finland has a key role in EU-OS and Finnish membership in EU-OS brings domestic scientists outstanding opportunities and access to technologies, services and resources not currently available in Finland. In this RI development project, we focus on enhancing our RI's capabilities in providing services in technology areas which are foreseen to provide novel research possibilities and potential for scientific breakthroughs for the users of our RI at national and international level.
Show more

Starting year

2024

End year

2026

Granted funding

Päivi Tammela Orcid -palvelun logo
610 678 €




Role in consortium of the Academy of Finland

Leader

Other consortium parties

Partner
University of Turku (358742)
311 333 €
Partner
Åbo Akademi University (358743)
77 834 €
Partner
University of Helsinki (358776)
407 960 €

Funder

Research Council of Finland

Funding instrument

Research infrastructure

Other information

Funding decision number

358646

Fields of science

Pharmacy

Research fields

Farmasia

Identified topics

molecular biology, biochemistry